Home/Filings/4/0001209191-17-045601
4//SEC Filing

JORN DEBORA 4

Accession 0001209191-17-045601

CIK 0001382911other

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 7:42 PM ET

Size

8.9 KB

Accession

0001209191-17-045601

Insider Transaction Report

Form 4
Period: 2017-07-14
JORN DEBORA
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-07-14+5,0005,000 total
    Exercise: $2.88Exp: 2027-07-13Common Stock (5,000 underlying)
Footnotes (1)
  • [F1]1/12th of the original number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest in equal monthly installments over 12 months following the vesting commencement date of July 14, 2017, subject to the Reporting Person's continuing service on the Issuer's Board of Directors through each such date, and subject to the terms of the Stock Option Agreement in the event of a change in control of the Issuer.

Issuer

Orexigen Therapeutics, Inc.

CIK 0001382911

Entity typeother

Related Parties

1
  • filerCIK 0001643304

Filing Metadata

Form type
4
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 7:42 PM ET
Size
8.9 KB